About: Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Sector: Healthcare
Industry: Medical Devices
Latest price: $165.02 (+6.56%)
PODD NASDAQ Insulet Corporation
Insulet Corporation share price
PODD price activity
Last Price
$165.020
Change (24hr)
10.16 USD (6.56%)
Volume
2.43M
Volume (4w avg)
-
Open
$148.61
Day Range
$148.55 - $165.46
Previous Close
$154.86
Last Trade
04 Nov, 9:14 pm GMT+0
Delayed
04 Nov, 9:14 pm GMT+0
PODD price performance
Delayed
04 Nov, 9:14 pm GMT+0
PODD details
PODD Market Signals